Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients

키워드

참고문헌 (34)

1. Naber D, "Good tolerability equals good results: the patient’s perspective", Eur Neuropsychopharmacol, 11(Suppl 4), pp.S391~S396 (2001)
2. Seon-Cheol Park, "Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis", Clinical Psychopharmacology and Neuroscience, 16(4), pp.361~375 (2018), 대한정신약물학회[DOI]
3. Verdoux H, "Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects", Acta Psychiatr Scand, 102, pp.203~210 (2000)
4. Babiker IE, "Noncompliance in schizophrenia", Psychiatr Dev, 4, pp.329~337 (1986)
5. Blackwell B, "Drug therapy : patient compliance", N Engl J Med, 289, pp.249~252 (1973)
6. Ascher-Svanum H, "The cost of relapse and the predictors of relapse in the treatment of schizophrenia", BMC Psychiatry, 10, pp.2~ (2010)
7. Day JC, "Attitudes toward antipsychotic medication : the impact of clinical variables and relationships with health professionals", Arch Gen Psychiatry, 62, pp.717~724 (2005)
8. Kao YC, "Compliance and schizophrenia : the predictive potential of insight into illness, symptoms, and side effects", Compr Psychiatry, 51, pp.557~565 (2010)
9. Murru A, "Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients", Acta Psychiatr Scand, 125, pp.412~418 (2012)
10. Sendt KV, "A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders", Psychiatry Res, 225, pp.14~30 (2015)
11. Lacro JP, "Prevalence of and risk factors for medication nonadherence in patients with schizophrenia : a comprehensive review of recent literature", J Clin Psychiatry, 63, pp.892~909 (2002)
12. Misdrahi D, "The influence of therapeutic alliance and insight on medication adherence in schizophrenia", Nord J Psychiatry, 66, pp.49~54 (2012)
13. Thompson K, "Reliability and validity of a new Medication Adherence Rating Scale(MARS)for the psychoses", Schizophr Res, 42, pp.241~247 (2000)
14. Svensson B, "Relationships among patient and therapist ratings of therapeutic alliance and patient assessments of therapeutic process : a study of cognitive therapy with long-term mentally ill patients", J Nerv Ment Dis, 187, pp.579~585 (1999)
15. Bordin ES, "The generalizability of the psychoanalytic concept of the working alliance", Psychother Theory Res Pract, 16, pp.252~260 (1979)
16. Krupnick JL, "The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome : findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program", J Consult Clin Psychol, 64, pp.532~539 (1996)
17. Weiss M, "The role of the alliance in the pharmacologic treatment of depression", J Clin Psychiatry, 58, pp.196~204 (1997)
18. Gaudiano BA, "Patients’ expectancies, the alliance in pharmacotherapy, and treatment outcomes in bipolar disorder", J Consult Clin Psychol, 74, pp.671~676 (2006)
19. Neale MS, "Therapeutic alliance and outcome in a VA intensive case management program", Psychiatr Serv, 46, pp.719~721 (1995)
20. Frank AF, "The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome", Arch Gen Psychiatry, 47, pp.228~236 (1990)
21. McCabe R, "The therapeutic relationship and adherence to antipsychotic medication in schizophrenia", PLoS One, 7, pp.e36080~ (2012)
22. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: 4th ed, text revision (DSM-IV-TR)" (2000), American Psychiatric Association
23. Morisky DE, "Concurrent and predictive validity of a self-reported measure of medication adherence", Med Care, 24, pp.67~74 (1986)
24. Hogan TP, "A self-report scale predictive of drug compliance in schizophrenics : reliability and discriminative validity", Psychol Med, 13, pp.177~183 (1983)
25. McGuire-Snieckus R, "A new scale to assess the therapeutic relationship in community mental health care : STAR", Psychol Med, 37, pp.85~95 (2007)
26. 권자영, "한국어판 치료적관계척도(STAR-K)의 타당화 연구", 정신건강과 사회복지, (35), pp.81~110 (2010), 한국정신건강사회복지학회
27. Amador XF, "Assessment of insight in psychosis", Am J Psychiatry, 150, pp.873~879 (1993)
28. Overall JE, "The brief psychiatric rating scales", Psychol Rep, 10, pp.799~812 (1962)
29. Nelson AA Jr, "Drug default among schizophrenic patients", Am J Hosp Pharm, 32, pp.1237~1242 (1975)
30. "Involuntary admission in high income country" (2015)[URL]
31. Fialko L, "A large-scale validation study of the Medication Adherence Rating Scale(MARS)", Schizophr Res, 100, pp.53~59 (2008)
32. Zemmour K, "Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia : results from the French housing first experience", Sci Rep, 6, pp.31598~ (2016)
33. Shattock L, "Therapeutic alliance in psychological therapy for people with schizophrenia and related psychoses : a systematic review", Clin Psychol Psychother, 25, pp.e60~ (2018)[DOI]
34. Jung E, "Perceived therapist genuineness predicts therapeutic alliance in cognitive behavioural therapy for psychosis", Br J Clin Psychol, 54, pp.34~48 (2015)

관련 논문AI추천